Search research articles
Contact Us
Filters
Showing results (151-160 of 266) with videos related to
Page
of 27
Sort By:
The Biochemical Journal
|
June 1, 1989
Structure of cDNA clones coding for the entire prepro alpha 1 (III) chain of human type III procollagen. Differences in protein structure from type I procollagen and conservation of codon preferences
L Ala-Kokko, S Kontusaari, C T Baldwin, et al.
Hepatology (Baltimore, Md.)
|
July 1, 1992
Hepatic fibrosis in rats produced by carbon tetrachloride and dimethylnitrosamine: observations suggesting immunoassays of serum for the 7S fragment of type IV collagen are a more sensitive index of liver damage than immunoassays for the NH2-terminal propeptide of type III procollagen
L Ala-Kokko, V Günzler, J B Hoek, et al.
Collagen and Related Research
|
July 1, 1982
Separation of human pro alpha 1 (I) and pro alpha 2 (I) procollagen chains by reverse phase high performance liquid chromatography
M Van der Rest, C A Stolle, D J Prockop, et al.
Journal of Cellular Biochemistry
|
October 28, 1999
Donor variation in the growth properties and osteogenic potential of human marrow stromal cells
D G Phinney, G Kopen, W Righter, et al.
American Journal of Human Genetics
|
September 1, 1992
Substitution of aspartate for glycine 1018 in the type III procollagen (COL3A1) gene causes type IV Ehlers-Danlos syndrome: the mutated allele is present in most blood leukocytes of the asymptomatic and mosaic mother
S Kontusaari, G Tromp, H Kuivaniemi, et al.
Matrix Biology : Journal of the International Society for Matrix Biology
|
August 26, 1998
A 1,064 bp fragment from the promoter region of the Col11a2 gene drives lacZ expression not only in cartilage but also in osteoblasts adjacent to regions undergoing both endochondral and intramembranous ossification in mouse embryos
S W Li, M Arita, G C Kopen, et al.
Human Genetics
|
December 1, 1991
Exclusion of COL1A1, COL1A2, and COL3A1 genes as candidate genes for Ehlers-Danlos syndrome type I in one large family
B P Sokolov, A N Prytkov, G Tromp, et al.
Matrix Biology : Journal of the International Society for Matrix Biology
|
March 21, 1998
A recombinant homotrimer of type I procollagen that lacks the central two D-periods. The thermal stability of the triple helix is decreased by 2 to 4 degrees C
K Zafarullah, A L Sieron, A Fertala, et al.
The Journal of Biological Chemistry
|
June 25, 1991
Heterozygous mutation in the G+5 position of intron 33 of the pro-alpha 2(I) gene (COL1A2) that causes aberrant RNA splicing and lethal osteogenesis imperfecta. Use of carbodiimide methods that decrease the extent of DNA sequencing necessary to define an unusual mutation
A Ganguly, C T Baldwin, D Strobel, et al.
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research
|
December 1, 1993
Mutations in type 1 procollagen that cause osteogenesis imperfecta: effects of the mutations on the assembly of collagen into fibrils, the basis of phenotypic variations, and potential antisense therapies
D J Prockop, A Colige, H Helminen, et al.
Page
of 27
Search research articles
Search
Showing results (151-160 of 266) with videos related to
Sort By:
Page
of 27
The Biochemical Journal
|
June 1, 1989
Structure of cDNA clones coding for the entire prepro alpha 1 (III) chain of human type III procollagen. Differences in protein structure from type I procollagen and conservation of codon preferences
L Ala-Kokko, S Kontusaari, C T Baldwin, et al.
Hepatology (Baltimore, Md.)
|
July 1, 1992
Hepatic fibrosis in rats produced by carbon tetrachloride and dimethylnitrosamine: observations suggesting immunoassays of serum for the 7S fragment of type IV collagen are a more sensitive index of liver damage than immunoassays for the NH2-terminal propeptide of type III procollagen
L Ala-Kokko, V Günzler, J B Hoek, et al.
Collagen and Related Research
|
July 1, 1982
Separation of human pro alpha 1 (I) and pro alpha 2 (I) procollagen chains by reverse phase high performance liquid chromatography
M Van der Rest, C A Stolle, D J Prockop, et al.
Journal of Cellular Biochemistry
|
October 28, 1999
Donor variation in the growth properties and osteogenic potential of human marrow stromal cells
D G Phinney, G Kopen, W Righter, et al.
American Journal of Human Genetics
|
September 1, 1992
Substitution of aspartate for glycine 1018 in the type III procollagen (COL3A1) gene causes type IV Ehlers-Danlos syndrome: the mutated allele is present in most blood leukocytes of the asymptomatic and mosaic mother
S Kontusaari, G Tromp, H Kuivaniemi, et al.
Matrix Biology : Journal of the International Society for Matrix Biology
|
August 26, 1998
A 1,064 bp fragment from the promoter region of the Col11a2 gene drives lacZ expression not only in cartilage but also in osteoblasts adjacent to regions undergoing both endochondral and intramembranous ossification in mouse embryos
S W Li, M Arita, G C Kopen, et al.
Human Genetics
|
December 1, 1991
Exclusion of COL1A1, COL1A2, and COL3A1 genes as candidate genes for Ehlers-Danlos syndrome type I in one large family
B P Sokolov, A N Prytkov, G Tromp, et al.
Matrix Biology : Journal of the International Society for Matrix Biology
|
March 21, 1998
A recombinant homotrimer of type I procollagen that lacks the central two D-periods. The thermal stability of the triple helix is decreased by 2 to 4 degrees C
K Zafarullah, A L Sieron, A Fertala, et al.
The Journal of Biological Chemistry
|
June 25, 1991
Heterozygous mutation in the G+5 position of intron 33 of the pro-alpha 2(I) gene (COL1A2) that causes aberrant RNA splicing and lethal osteogenesis imperfecta. Use of carbodiimide methods that decrease the extent of DNA sequencing necessary to define an unusual mutation
A Ganguly, C T Baldwin, D Strobel, et al.
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research
|
December 1, 1993
Mutations in type 1 procollagen that cause osteogenesis imperfecta: effects of the mutations on the assembly of collagen into fibrils, the basis of phenotypic variations, and potential antisense therapies
D J Prockop, A Colige, H Helminen, et al.
Page
of 27